Delivery Order SPE2DB22D2211-SPE2DB25FSDVF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for Topiramate ER 200 mg capsules (30-count units) with a ceiling value of $5,626.87. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of October 21, 2025. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,365.81 to AmerisourceBergen Drug Corp for Topiramate ER 200 mg capsules (30-count units) on August 12, 2025, with completion scheduled for August 13, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded a delivery order valued at $1,882.48 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Topiramate ER 25 mg capsules (30-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of August 19, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary operations center. This...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 200 mg Topiramate ER capsules. The $48,858.73 contract has an ultimate completion date of April 10, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the pharmaceutical products from its Corporate Office location in Conshohocken, Pennsylvania to...
- The Defense Logistics Agency awarded a delivery order valued at $5,717.72 to AmerisourceBergen Drug Corp for the supply of Topiramate ER 200 mg capsules (30-count) on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania location. The order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,221.18 to AmerisourceBergen Drug Corp for the supply of Topiramate ER 100 mg capsules (30-count units) on October 16, 2025, with an ultimate completion date of October 17, 2025. This is a firm fixed price, non-set-aside contract for delivery to the company's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting the federal government's medical supply needs....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Topiramate ER 100 mg capsules (30-count units) with a ceiling value of $5,421.03. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is located in Conshohocken, Pennsylvania, the company's headquarters, with an ultimate completion date of August 26, 2025. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,341.04 to AmerisourceBergen Drug Corp for the supply of Topiramate ER 200 mg capsules (30-count units). This firm fixed-price delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a competitively awarded, non-set-aside contract. The product will be delivered to Conshohocken, Pennsylvania, where the vendor maintains its corporate office. This delivery order operates under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,670.52 on September 2, 2025, for the supply of Topiramate ER 200 mg capsules (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 3, 2025, and performance to be executed from the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a relatively small-value transaction within the broader federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $6,195.98 to AmerisourceBergen Drug Corp for the supply of Topiramate ER 100 mg capsules (30-count packages) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract was performed at the vendor's corporate office location in Conshohocken, Pennsylvania, and carries no set-aside designation. The delivery order represents a child contract action under...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSDVFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Topiramate ER 200 mg capsules (30-count units) with a ceiling value of $2,157.41. This is a firm fixed price, non-set-aside contract awarded on August 27, 2025, with an ultimate completion date of August 28, 2025. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen is a major pharmaceutical distributor and established federal vendor that supplies a broad range of medications, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company consistently wins competitive awards from DLA for pharmaceutical products across multiple therapeutic domains, demonstrating its capability to meet federal procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/27/25 |